Human UDP-Glucose 4-Epimerase (GALE) Protein

Product Graph
377€ (10 µg)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Human UDP-Glucose 4-Epimerase (GALE) Protein
category
Proteins and Peptides
provider
Abbexa
reference
abx692907
tested applications
SDS-PAGE

Description

Udp-Glucose 4-Epimerase (GALE) protein is a recombinant Human protein expressed in E. coli.

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Proteins and Peptides
Immunogen Target
Udp-Glucose 4-Epimerase (GALE)
Host
E. coli
Assay Type
Activity: Not tested
Sequence Fragment: Met1-Ala348
Tag: N-terminal 6 His tag
Origin
Human
Observed MW
40.4 kDa
Expression
Recombinant
Purity
> 95% (SDS-PAGE)
Size 1
10 µg
Size 2
50 µg
Form
Liquid
Tested Applications
SDS-PAGE
Buffer
50 mM TrisHCl, 150 mM NaCl, 2 mM DTT, 1 mM EDTA, pH 8.0.
Availability
Shipped within 5-15 working days.
Storage
Aliquot and store at -20 °C. Avoid repeated freeze/thaw cycles.
Shelf Life: 6 months.
Dry Ice
No
UniProt ID
Q14376
Background
Protein GALE
Status
RUO
Note
THIS PRODUCT IS FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC, THERAPEUTIC OR COSMETIC PROCEDURES. NOT FOR HUMAN OR ANIMAL CONSUMPTION.
Endotoxin Level: < 1.0 EU per µg (LAL method).

Descripción

Related Products

FNab03309

GALE antibody

This gene encodes UDP-galactose-4-epimerase which catalyzes two distinct but analogous reactions: the epimerization of UDP-glucose to UDP-galactose, and the epimerization of UDP-N-acetylglucosamine to UDP-N-acetylgalactosamine. The bifunctional nature of the enzyme has the important metabolic consequence that mutant cells (or individuals) are dependent not only on exogenous galactose, but also on exogenous N-acetylgalactosamine as a necessary precursor for the synthesis of glycoproteins and glycolipids. Mutations in this gene result in epimerase-deficiency galactosemia, also referred to as galactosemia type 3, a disease characterized by liver damage, early-onset cataracts, deafness and mental retardation, with symptoms ranging from mild (&apos;peripheral&apos; form) to severe (&apos;generalized&apos; form). Multiple alternatively spliced transcripts encoding the same protein have been identified.

Ver Producto
P5787

Recombinant Human GALE

Ver Producto
abx005057

UDP-Glucose 4-Epimerase (GALE) Antibody

GALE Antibody is a Rabbit Polyclonal antibody against GALE. This gene encodes UDP-galactose-4-epimerase which catalyzes two distinct but analogous reactions: the epimerization of UDP-glucose to UDP-galactose, and the epimerization of UDP-N-acetylglucosamine to UDP-N-acetylgalactosamine. The bifunctional nature of the enzyme has the important metabolic consequence that mutant cells (or individuals) are dependent not only on exogenous galactose, but also on exogenous N-acetylgalactosamine as a necessary precursor for the synthesis of glycoproteins and glycolipids. Mutations in this gene result in epimerase-deficiency galactosemia, also referred to as galactosemia type 3, a disease characterized by liver damage, early-onset cataracts, deafness and mental retardation, with symptoms ranging from mild ('peripheral' form) to severe ('generalized' form). Multiple alternatively spliced transcripts encoding the same protein have been identified.

Ver Producto